A61K 47/6941
The form being a granulate or an agglomerate
Official title: {the form being a granulate or an agglomerate}
A61K47/6941 (The form being a granulate or an agglomerate) appears on 53 US grants and 72 published applications in this corpus.
Search patents in A61K- Granted patents
- 53
- Published applications
- 72
- Assignees
- 46
- Inventors
- 130
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 3 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 3 | 6 |
| 2013 | 1 | 2 |
| 2014 | 1 | 4 |
| 2015 | 3 | 7 |
| 2016 | 7 | 4 |
| 2017 | 5 | 10 |
| 2018 | 5 | 3 |
| 2019 | 3 | 9 |
| 2020 | 3 | 2 |
| 2021 | 7 | 6 |
| 2022 | 1 | 1 |
| 2023 | 2 | 3 |
| 2024 | 2 | 3 |
| 2025 | 3 | 2 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Application of AuCs or substances containing AuCs in the preparation of drugs for preventing and/or treating glaucoma5 Aug 2025US 12,377,167 B2Shenzhen Profound-View Pharma Tech Co., Ltd
- Magnetic particle control and visualization29 Jul 2025US 12,370,259 B2Pulse Therapeutics, Inc.
- Pharmaceutical composition comprising polypeptide24 Jun 2025US 12,338,270 B2D&D Pharmatech Inc.
- Nanoparticle delivery system for targeted anti-obesity treatment8 Oct 2024US 12,109,268 B2University of Wyoming
- Application of AuCs or substances containing AuCs in the preparation of drugs for preventing and/or treating glaucoma30 Apr 2024US 11,969,477 B2Shenzhen Profound-View Pharma Tech Co., Ltd
- Broad-spectrum antibiotic hybrids for the treatment of multi-drug resistant infections1 Oct 2026US 2026/0295059 A1Monash University
- Cyclodextrin-poly (beta amino ester) macromolecules for nanoparticle drug delivery23 Jul 2026US 2026/0207508 A1
- Imaging-guided bioresorbable acoustic hydrogel microrobots11 Jun 2026US 2026/0157972 A1California Institute of Technology
- Pharmaceutical composition comprising polypeptide28 Aug 2025US 2025/0270275 A1D&D Pharmatech Inc.
- Nanoparticles for direct regulation of mitochondrial gene expression29 May 2025US 2025/0170269 A1Rutgers, The State University of New Jersey
Most cited
By later US patents
- Ionophore containing liposomes for ultrasound imaging145US 5,352,435 A1994
- Small organometallic probes117US 5,521,289 ANanoprobes, Inc. · 1996
- Therapeutic magnetic control systems and contrast agents95US 10,029,008 B2Pulse Therapeutics, Inc. · 2018
- Biodegradable magnetic microcluster comprising non-magnetic metal or metal oxide particles coated with a functionalized polymer32US 5,225,282 AMolecular BioQuest, Inc. · 1993
- Liposomes as contrast agents for ultrasonic imaging and apparatus and methods for preparing the same31US 5,571,497 AImaRx Pharmaceutical Corp. · 1996